Tiger Newspress16:16
Biotechnology company TenNor Therapeutics jumped 48% in Hong Kong’s grey market trading.
TenNor Therapeutics is a near-commercial stage biotechnology company, incorporated in 2013 and focused on the development, manufacturing, and commercialization of innovative anti-infective drugs. The company addresses critical unmet needs in infectious diseases, with an emphasis on multi-drug resistant pathogens.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
